Metropolitan Life Insurance Company (MetLife)’s Ebix Inc EBIX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EBIX Stock Details EBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,488	Closed	-$14.7K	–	2427
2023 Q3	$14.7K	Hold	1,488	–	–	﹤0.01%	2040
2023 Q2	$37.5K	Hold	1,488	–	–	﹤0.01%	1597
2023 Q1	$19.6K	Sell	1,488 -357	-19%	-$6.21K	﹤0.01%	1896
2022 Q4	$36.8K	Hold	1,845	–	–	﹤0.01%	1661
2022 Q3	$35K	Hold	1,845	–	–	﹤0.01%	1703
2022 Q2	$31.2K	Hold	1,845	–	–	﹤0.01%	1793
2022 Q1	$61.2K	Sell	1,845 -4,431	-71%	-$138K	﹤0.01%	1477
2021 Q4	$191K	Sell	6,276 -1,500	-19%	-$47.8K	﹤0.01%	2060
2021 Q3	$209K	Hold	7,776	–	–	﹤0.01%	2030
2021 Q2	$264K	Buy	7,776 +638	+9%	+$19.8K	﹤0.01%	1956
2021 Q1	$229K	Sell	7,138 -476	-6%	-$18.4K	﹤0.01%	1923
2020 Q4	$289K	Hold	7,614	–	–	﹤0.01%	1695
2020 Q3	$157K	Hold	7,614	–	–	﹤0.01%	1932
2020 Q2	$170K	Hold	7,614	–	–	﹤0.01%	1910
2020 Q1	$116K	Hold	7,614	–	–	﹤0.01%	1947
2019 Q4	$254K	Hold	7,614	–	–	﹤0.01%	1754
2019 Q3	$321K	Hold	7,614	–	–	0.01%	1569
2019 Q2	$382K	Hold	7,614	–	–	0.01%	1473
2019 Q1	$376K	Hold	7,614	–	–	0.01%	1478
2018 Q4	$324K	Hold	7,614	–	–	0.01%	1500
2018 Q3	$603K	Hold	7,614	–	–	0.01%	1233
2018 Q2	$581K	Hold	7,614	–	–	0.01%	1213
2018 Q1	$567K	Buy	7,614 +103	+1%	+$8.37K	0.01%	1193
2017 Q4	$595K	Sell	7,511 -9,454	-56%	-$687K	0.01%	1166
2017 Q3	$1.11M	Sell	16,965 -500	-3%	-$28.8K	0.01%	1192
2017 Q2	$941K	Buy	17,465 +133	+0.8%	+$7.66K	0.01%	1277
2017 Q1	$1.06M	Sell	17,332 -253	-1%	-$15K	0.01%	1200
2016 Q4	$1M	Sell	17,585 -1,288	-7%	-$74.8K	0.01%	1291
2016 Q3	$1.07M	Hold	18,873	–	–	0.01%	1244
2016 Q2	$904K	Sell	18,873 -270	-1%	-$12.4K	0.01%	1316
2016 Q1	$781K	Hold	19,143	–	–	0.01%	1301
2015 Q4	$628K	Sell	19,143 -556	-3%	-$17.6K	﹤0.01%	1483
2015 Q3	$492K	Hold	19,699	–	–	﹤0.01%	1649
2015 Q2	$642K	Sell	19,699 -4,042	-17%	-$130K	﹤0.01%	1584
2015 Q1	$721K	Sell	23,741 -1,836	-7%	-$46.1K	0.01%	1381
2014 Q4	$435K	Hold	25,577	–	–	﹤0.01%	1860
2014 Q3	$363K	Hold	25,577	–	–	﹤0.01%	1939
2014 Q2	$366K	Hold	25,577	–	–	﹤0.01%	2062
2014 Q1	$437K	Hold	25,577	–	–	﹤0.01%	1907
2013 Q4	$376K	Hold	25,577	–	–	﹤0.01%	2015
2013 Q3	$254K	Hold	25,577	–	–	﹤0.01%	2242
2013 Q2	$237K	Buy	+25,577	New	+$457K	﹤0.01%	2232

Other funds holding EBIX

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

DTL

Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EBIX Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ebix Inc (EBIX) in Q4 2023, closing a stake of 1,488 shares — an estimated $14.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EBIX in Q2 2013 and held it in 42 quarters. The position peaked at $1.11M in Q3 2017. 10 funds tracked by Wall St. Rank hold EBIX as of Q4 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ebix Inc position as of Q4 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,488 Ebix Inc shares in Q4 2023, an estimated $14.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ebix Inc in Q2 2013 and held it in 42 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ebix Inc position peaked at $1.11M in Q3 2017.
10 funds tracked by Wall St. Rank held Ebix Inc as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.